JP2023109826A5 - - Google Patents

Info

Publication number
JP2023109826A5
JP2023109826A5 JP2023077029A JP2023077029A JP2023109826A5 JP 2023109826 A5 JP2023109826 A5 JP 2023109826A5 JP 2023077029 A JP2023077029 A JP 2023077029A JP 2023077029 A JP2023077029 A JP 2023077029A JP 2023109826 A5 JP2023109826 A5 JP 2023109826A5
Authority
JP
Japan
Prior art keywords
composition
compound
tlr4
formulated
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023077029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023109826A (ja
Filing date
Publication date
Priority claimed from JP2020571384A external-priority patent/JP7728560B2/ja
Application filed filed Critical
Publication of JP2023109826A publication Critical patent/JP2023109826A/ja
Publication of JP2023109826A5 publication Critical patent/JP2023109826A5/ja
Pending legal-status Critical Current

Links

JP2023077029A 2018-07-02 2023-05-09 新規免疫調節小分子 Pending JP2023109826A (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201862693023P 2018-07-02 2018-07-02
US62/693,023 2018-07-02
JP2020571384A JP7728560B2 (ja) 2018-07-02 2019-07-02 新規免疫調節小分子
US16/460,211 US11364253B2 (en) 2018-07-02 2019-07-02 Immunodulating small molecules
US16/460,211 2019-07-02
PCT/US2019/040313 WO2020010090A1 (en) 2018-07-02 2019-07-02 Novel immunodulating small molecules

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2020571384A Division JP7728560B2 (ja) 2018-07-02 2019-07-02 新規免疫調節小分子

Publications (2)

Publication Number Publication Date
JP2023109826A JP2023109826A (ja) 2023-08-08
JP2023109826A5 true JP2023109826A5 (https=) 2025-11-11

Family

ID=69060166

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020571384A Active JP7728560B2 (ja) 2018-07-02 2019-07-02 新規免疫調節小分子
JP2023077029A Pending JP2023109826A (ja) 2018-07-02 2023-05-09 新規免疫調節小分子

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2020571384A Active JP7728560B2 (ja) 2018-07-02 2019-07-02 新規免疫調節小分子

Country Status (8)

Country Link
US (1) US11364253B2 (https=)
JP (2) JP7728560B2 (https=)
KR (1) KR20210027381A (https=)
AU (1) AU2019297321B2 (https=)
BR (1) BR112020026989A2 (https=)
CA (1) CA3103503A1 (https=)
MX (1) MX2020014087A (https=)
WO (1) WO2020010090A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220143059A1 (en) * 2016-03-30 2022-05-12 Ayuvis Research, Inc. Compositions and therapeutic methods
US12594286B2 (en) 2018-07-02 2026-04-07 Ayuvis Research, Inc. Immunodulating small molecules
US20220241306A1 (en) * 2021-02-04 2022-08-04 Ayuvis Research, Inc. Chitin analogs for the treatment of kidney diseases
US12440471B2 (en) * 2021-07-30 2025-10-14 Ayuvis Research, Inc. Compositions and methods for the treatment of bronchopulmonary dysplasia (BPD) and BPD-associated pulmonary hypertension
CA3237508A1 (en) * 2021-11-12 2023-05-19 Suchismita ACHARYA Novel compositions and therapeutic methods
CA3257177A1 (en) * 2022-05-25 2023-11-30 Ayuvis Research, Inc. NEW SMALL IMMUNOMOLATORY MOLECULES
WO2024220628A1 (en) * 2023-04-18 2024-10-24 The Regents Of The University Of Colorado, A Body Corporate Target for combatting the foreign body response to implantable biomaterials
US20250332183A1 (en) * 2024-04-30 2025-10-30 Ayuvis Research, Inc. Compositions and methods for the stimulation of intermediate macrophages and treatments therewith

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931319A (en) 1974-10-29 1976-01-06 Millmaster Onyx Corporation Capped polymers
US4027020A (en) 1974-10-29 1977-05-31 Millmaster Onyx Corporation Randomly terminated capped polymers
US4525346A (en) 1981-09-28 1985-06-25 Alcon Laboratories, Inc. Aqueous antimicrobial ophthalmic solutions
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US4404365A (en) * 1981-12-28 1983-09-13 American Cyanamid Company Modulators of the complement system
US4836986A (en) 1984-09-28 1989-06-06 Bausch & Lomb Incorporated Disinfecting and preserving systems and methods of use
US4621075A (en) 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
US4806352A (en) 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
ES2037072T3 (es) 1986-12-19 1993-06-16 Duphar International Research B.V Suspension coadyuvante estabilizada que comprende bromuro de dimetil-dioctadecil-amonio.
EP0283085B1 (en) 1987-03-17 1992-11-11 Akzo N.V. Adjuvant mixture
US5037647A (en) 1988-09-15 1991-08-06 Alcon Laboratories, Inc. Aqueous antimicrobial opthalmic solutions comprised of quaternary ammonium compound, citric acid, citrate and sodium chloride
US5145643A (en) 1990-01-05 1992-09-08 Allergan, Inc. Nonoxidative ophthalmic compositions and methods for preserving and using same
US5300287A (en) 1992-11-04 1994-04-05 Alcon Laboratories, Inc. Polymeric antimicrobials and their use in pharmaceutical compositions
US5736522A (en) * 1993-11-15 1998-04-07 Kureha Chemical Industry Co., Ltd. Esculetin derivatives and method for manufacture thereof, use thereof, and pharmaceutical composition
AU7484198A (en) 1997-05-12 1998-12-08 Sage Pharmaceuticals, Inc. Topical spray for burn treatment and anti-infection
ATE265218T1 (de) * 2000-08-10 2004-05-15 Ocean Nutrition Canada Ltd Chlorella zubereitungen mit immunmodulatorischen eigenschaften
WO2005115336A2 (en) 2004-05-15 2005-12-08 Collegium Pharmaceutical, Inc. Sprayable formulations for the treatment of acute inflammatory skin conditions
JP2010502766A (ja) * 2006-06-16 2010-01-28 フロリダ アトランティック ユニヴァーシティ アジュバントとしてのキチン微粒子
EP3240411A4 (en) * 2014-11-12 2019-02-20 Tumorend LLC COMPOSITIONS, METHODS AND TREATMENTS FOR INHIBITING CELL ADHESION AND VIRUS BINDING AND PENETRATION
CA3015494C (en) * 2016-03-30 2021-10-26 Ayuvis Research, Inc. Novel compositions and therapeutic methods

Similar Documents

Publication Publication Date Title
JP2023109826A5 (https=)
JP2021535080A5 (https=)
JP2022180461A5 (https=)
US4738984A (en) Antirhinovirus agents
US9511019B2 (en) Pharmaceutical compositions for treating IBD
US5514667A (en) Method for topical treatment of herpes infections
JP2011516672A5 (https=)
JP2014516942A5 (https=)
EP0831815A1 (en) Use of bis-1,2,4-triazoles for the manufacture of a medicament for the treatment of cancers
CN1323660C (zh) 治疗病毒性皮肤和肿瘤疾病的药物
JP2007291067A (ja) 医薬組成物
EP1147086A1 (en) Compositions for the treatment of skin diseases
ROSTEN Hydroxyurea: a new antimetabolite in the treatment of psoriasis
JP3122748B2 (ja) イブプロフェン含有解熱鎮痛剤
AU742929B2 (en) Viral inhibition by long-chain alcohols, alkanes, fatty acids and amides
JPWO2020010090A5 (https=)
WO2007108272A1 (ja) 癌治療用キットおよび癌治療用医薬組成物
CN113101289A (zh) 烟酰胺在制备治疗手足皮肤反应制剂中的应用
US8148425B2 (en) Pharmaceutical composition containing phloroglucinol and paracetamol
FI4199922T3 (fi) (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa
JPH0345055B2 (https=)
IL319025A (en) Methods for treating or preventing endometriosis
JP7644128B2 (ja) 生物活性コポリマーの調製のためのプロセス
EP3337512A1 (en) A topical antiviral composition
JP2000159674A (ja) 解熱鎮痛消炎剤